Market revenue in 2023 | USD 222.3 million |
Market revenue in 2030 | USD 316.4 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Endoscopes |
Fastest growing segment | Single Photon Emission Computed Tomography (SPECT) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI), Endoscopes, X-ray Fluoroscopy, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT) |
Key market players worldwide | Koninklijke Philips NV, Medtronic PLC, Siemens Healthineers AG ADR, Analogic Corporation, GE HealthCare Technologies Inc Common Stock, BrainLAB, Olympus Corp, Stryker Corp, Varian |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to image-guided therapy systems market will help companies and investors design strategic landscapes.
Endoscopes was the largest segment with a revenue share of 33.96% in 2023. Horizon Databook has segmented the UK image-guided therapy systems market based on computed tomography (ct) scanners, ultrasound systems, magnetic resonance imaging (mri), endoscopes, x-ray fluoroscopy, positron emission tomography (pet), single photon emission computed tomography (spect) covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in geriatric population and the subsequent rise in chronic disease burden, as well as favorable initiatives undertaken by organizations in development of technologically advanced cancer imaging systems, are among the key factors likely to boost the adoption of image-guided therapy systems in the UK.
There is rapid adoption of image-guided radiotherapy for prostate cancer treatment in radiotherapy centers across the UK. According to GLOBCAN 2020, breast, colon, prostrate, and lung cancers are among the most prevalent types in the country.
Thus, there is a growing demand for image-guided therapy systems in the UK for the management of cancer. Koninklijke Philips N.V.; GE Healthcare; Medtronic; and Stryker are among key players in the market.
Horizon Databook provides a detailed overview of country-level data and insights on the UK image-guided therapy systems market , including forecasts for subscribers. This country databook contains high-level insights into UK image-guided therapy systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account